Drug-coated balloon versus drug-eluting stent: the debate of leave nothing behind

N Keefe, T Shull, L Botea… - Seminars in …, 2023 - thieme-connect.com
Endovascular techniques for peripheral artery disease have changed significantly in the
past 10 years with advances in technology and data. Treatment of superficial femoral …

Efficacy analysis following polymer coated drug eluting stent and bare metal stent deployment for femoropopliteal arterial disease

Y Shehada, T Bisdas, A Argyriou, G Torsello… - …, 2024 - journals.sagepub.com
Objectives The objective is to assess the performance of the Eluvia polymer coated drug
eluting stent (DES) compared to a bare metal stent (BMS) platform in patients with …

[HTML][HTML] Use of paclitaxel-coated balloons in clinical setting is not associated with increased mortality compared with plain balloon angioplasty in femoropopliteal …

V Kalbus, JM Kärkkäinen, W Wallin, M Kettunen… - Journal of Vascular …, 2022 - Elsevier
Objective To investigate mortality and causes of death associated with the use of paclitaxel-
coated balloon (PCB) compared with plain balloon (PB) angioplasty in the treatment of …

High-Risk Characteristics for Clinical Failure after Isolated Femoropopliteal Peripheral Vascular Interventions

TI Kim, PA Schneider, J Iannuzzi, CIO Chaar - Annals of Vascular Surgery, 2023 - Elsevier
Background Recent studies suggesting increased late mortality with paclitaxel-coated
devices (PCDs) in femoropopliteal peripheral vascular interventions (PVIs) prompted the US …

[PDF][PDF] Paklitakselilla päällystetty lääkepallo ja tavallinen pallolaajennus alaraajaiskemian hoidossa: vaikutus kuolleisuuteen

M Kettunen - 2024 - erepo.uef.fi
Paklitakselilla päällystetty lääkepallo ja tavallinen pallolaajennus alaraajaiskemian hoidossa:
vaikutus kuolleisuuteen Page 1 Paklitakselilla päällystetty lääkepallo ja tavallinen …